A. León

M. Terol, J. S. San Miguel, J. Ribera, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.

N. Kröger, A. Zander, R. Brand, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.

J. Garcia-conde, C. Craddock, S. Mackinnon, 2002, Blood.

Hematopoietic abnormalities persist for more than six years after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma.

L. Hermosín, Alejandro Martín, N. López-Holgado, 2004, Haematologica.

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

L. Escoda, D. Colomer, Marcos González, 2003, Blood.

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.

J. Esteve, M. Tormo, Marcos González, 2009, Blood.

The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma.

C. Solano, J. Rodríguez, J. Lahuerta, 2007, Haematologica.

The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience.

R. Arranz, A. Gutiérrez, M. Caballero, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.

A. F. Sevilla, José Raúl Rodríguez Rodríguez, J. San-Miguel, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.

A. López-Guillermo, J. Sierra, J. Rodríguez, 2003, Haematologica.

Frontline autologous stem cell transplantation in high‐risk peripheral T‐cell lymphoma: a prospective study from The Gel‐Tamo Study Group

J. Rodríguez, R. Arranz, A. Gutiérrez, 2007, European journal of haematology.

Prolonged survival of patients with angioimmunoblastic T‐cell lymphoma after high‐dose chemotherapy and autologous stem cell transplantation. The GELTAMO experience

J. Rodríguez, J. Ribera, J. Moraleda, 2007, European journal of haematology.

Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy.

J. Garcia-conde, C. Solano, C. Richard, 1992, Bone marrow transplantation.

Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome.

J. Garcia-conde, M. Terol, F. Hernández-Navarro, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

A. López-Guillermo, J. Garcia-conde, J. Rifón, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.

J. Esteve, D. Colomer, Marcos González, 2008, Blood.

Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience.

A. López-Guillermo, A. F. Sevilla, J. Sierra, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors

M. González, J. Rifón, M. Corral, 1997, Bone Marrow Transplantation.

lymphoproliferative disorders comparison between 2 prospective studies in patients with Nonmyeloablative transplantation with or without alemtuzumab

J. Miguel, C. Craddock, D. Linch, 2013 .

NON-MYELOABLATIVE TRANSPLANTS WITH OR WITHOUT CAMPATH-1H: COMPARISON BETWEEN TWO PROSPECTIVE STUDIES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS.

Dolores, J. Garcia-conde, C. Craddock, 2002 .

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation

J. S. San Miguel, M. D. del Cañizo, S. Brunet, 2005, British journal of haematology.

Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: A report from the Spanish GEL/TAMO Cooperative Group

E. Montserrat, J. Garcia-conde, C. Solano, 1993, Annals of Hematology.

Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial

C. Solano, J. Besalduch, J. Pérez-Simón, 2004, Bone Marrow Transplantation.

Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on)

J. Román, F. Velasco, J. Serrano, 1999, Bone Marrow Transplantation.

Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients

J. San-Miguel, J. Bladé, J. Lahuerta, 2000, British journal of haematology.

Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens

A. López-Guillermo, A. Salar, A. Grañena, 2001, Bone Marrow Transplantation.

Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa.

A. Grañena, D. Colomer, J. A. Castillejo, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study

Alejandro Martín, Rafael Andreu, A. Salar, 2008, Haematologica.

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.

J. Esteve, M. Tormo, Marcos González, 2008, Blood.

Myeloablative Treatments for Multiple Myeloma: Update of a Comparative Study of Different Regimens Used in Patients from the Spanish Registry for Transplantation in Multiple Myeloma

J. Miguel, C. Solano, J. Bargay, 2002, Leukemia & lymphoma.

Influence of the Intensity of the Conditioning Regimen on the Characteristics of Acute and Chronic Graft Versus Host Disease after Allogeneic Transplantation.

J. Miguel, J. Sierra, S. Brunet, 2004 .

R-ESHAP as Salvage Therapy for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Spanish GEL-TAMO Multicenter Study.

A. Salar, E. González-Barca, M. Requena, 2007 .

Prognostic factors in patients who received autologous bone marrow transplantation for non-Hodgkin's lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL/TAMO.

J. Garcia-conde, A. Domingo, J. Sierra, 1994, Bone marrow transplantation.

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.

J. Esteve, M. Tormo, E. Vellenga, 2008, Blood.

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.

C. Solano, S. Brunet, F. Hernández-Navarro, 1998, Bone Marrow Transplantation.

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.

M. Tormo, J. Bergua, B. Lowenberg, 2008, Blood.

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma.

J. S. San Miguel, J. Pérez-Simón, J. Bladé, 2008, Blood.